netFormulary Bradford Teaching Hospitals NHS
NHS Foundation Trust Formulary  

Looking for Apremilast found 5 matches

Open monograph to display formulary status BNF Category
  Apremilast  (Otezla)
Skin - Drugs affecting the immune response - 13.05.03
  Restricted Drug Apremilast  (Otezla) Malignant disease and immunosuppression - Immunosuppressant therapy - 08.02

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Jan 2017): Apremilast (Otezla ): risk of suicidal thoughts and behaviour (08.02)
link in drug section NICE TA419: Apremilast for treating moderate to severe plaque psoriasis (08.02)
link in drug section NICE TA433: Apremilast for treating active psoriatic arthritis  (08.02)